SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
20.20
-0.15 (-0.74%)
At close: Jul 24, 2026
ETR:1SXP Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, ETR:1SXP stock has a consensus rating of "Buy" and an average price target of €20.43. The average 1-year stock price forecast is 1.14% higher than the current stock price, while the lowest is €13.00 (-35.64%) and the highest is €25.90 (+28.22%).
Price Target: €20.43 (+1.14%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ETR:1SXP stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 5 | 5 | 5 | 5 | 5 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 12 |
Financial Forecast
Revenue This Year
1.02B
from 986.21M
Increased by 3.26%
Revenue Next Year
1.09B
from 1.02B
Increased by 6.90%
EPS This Year
0.95
from 0.97
Decreased by -1.93%
EPS Next Year
1.07
from 0.95
Increased by 12.34%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.